Heat Biologics Shares Continue Higher (Up 22%) on Heavy Volume Fri. Following 27% Run-Up on Wed. as $1.50 Resistance Level Breached; BZ NOTE: Co. Announced Last Thursday It will Be Reporting Phase Ib Results for HS-110 In Combo with Bristol's Opdivo Dec.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.